Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

4502 5,200.00 -62.00 (-1.18%)
price chart
Moody's confirms Takeda Pharmaceutical's A1 ratings; outlook negative
Takeda Pharmaceutical Company Limited is the largest pharmaceutical company in Japan in terms of revenue. It has well-established business franchises in Japan, the US and EU, and a presence in over 70 countries.
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership ...
Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. (TSE:4502) from the realm of small molecule discovery into the new research area of antibody drug discovery. All three ...
BRIEF-Takeda Pharmaceutical says PRA Health Sciences and Takeda Partnership ...
Feb 15 Takeda Pharmaceutical Co Ltd : * Says PRA Health Sciences Inc and Takeda Pharmaceutical Company Limited have agreed to a new partnership to expand their global relationship initially disclosed in September 2016 to include Japan.
Takeda and PRA Health Sciences Announce Transformational Clinical Development ...
OSAKA, Japan & RALEIGH, N.C.--(BUSINESS WIRE)--PRA Health Sciences, Inc. (NASDAQ: PRAH) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have entered into a new partnership agreement under ...
Raleigh's PRA Health signs 'transformational' deal with Takeda  Triangle Business Journal
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion deal
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) (“Ariad”) today announced that they have entered into a definitive agreement under which Takeda will ...
Takeda Pays 2012 Price For 2017 Model ARIAD  Seeking Alpha
BRIEF-Takeda Pharmaceutical & Ovid Therapeutics announces clinical development ...
Jan 18 Takeda Pharmaceutical Co Ltd: * Takeda and Ovid Therapeutics announce innovative clinical development, commercialization collaboration for TAK-935 in rare pediatric epilepsies.
Takeda teams up with Ovid Therapeutics to develop epilepsy drug  Seeking Alpha
Takeda, Ovid to Co-Develop Rare Pediatric Epilepsy Candidate TAK-935  Genetic Engineering & Biotechnology News (blog)
Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital ...
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research, ...
Takeda notifies 4.48% shareholding in TiGenix
Persons subject to the notification requirement: related companies Takeda Pharmaceutical Company Limited (with address at 1-1, Doshomachi 4-Chome, Chuo-ku, Osaka 540-8645, Japan), who is a parent undertaking/controlling person, and Takeda ...
Cambridge Cognition in study with Takeda Pharmaceutical for Apple Watch app ...
Cambridge Cognition Holdings plc (LON:COG) has teamed up with Takeda Pharmaceutical Company Ltd to pilot the use of an Apple Watch app that monitors patients with major depression disorder.
Apple Watch Study to Use Digital Health to Tackle Depression  mHealthIntelligence.com